A decade-old string of lawsuits that has embroiled seven life sciences firms is closer to resolution following a recent ruling.
Judge Richard Sullivan of the US District Court of the Southern District of New York on Sept. 21 granted in part and denied in part combined and individual motions from Affymetrix, Amersham, Molecular Probes, Orchid Biosciences, PerkinElmer, and Roche Diagnostics for summary judgment, ruling that they do not infringe IP owned by Enzo Biochem and its wholly owned subsidiary Enzo Life Sciences.